14 results for «165»
14 results
Transcatheter options for degenerated surgical aortic valves - LIVE case
Recommended by PCR
08 Feb 2025 – From PCR Tokyo Valves 2025
A 77-year-old male with a history of SAVR in 2011 (Magna Ease 23) and moderate chronic kidney disease, with preservedLV function, presented with symptomatic severe aortic regurgitation and stenosis, associated with severe MR.
A Sapien 3 Ultra Resilia 23 valve was implanted under local anesthesia, with hemodynamic...
Transcatheter management of failed THV - LIVE case
Recommended by PCR
09 Feb 2025 – From PCR Tokyo Valves 2025
An 84-year-old woman with diabetes mellitus, frailty (5/6), preserved LV function, and aortic stenosis previously treated with CoreValve 26 mm in 2016, presented with symptomatic degenerative stenosis of the valve.
A Sapien 3 (23 mm) was implanted without predilatation but with post-dilatation under general anaesthesia, using cerebral...
Imaging-guided left main PCI - LIVE case
Recommended by PCR
17 May 2024 – From EuroPCR 2024
A 53-year-old male with a history of advanced malignancy (lung adenoma) and mid LAD PCI last year, along with multiple risk factors (hypertension, dyslipidemia, diabetes, and smoking), presented with angina and a positive stress test and CT. The angiography and CT showed significant left main stenosis...
Transcatheter tricuspid valve replacement - LIVE case
Recommended by PCR
15 May 2024 – From EuroPCR 2024
An 82-year-old male with a history of STEMI in 2013, stroke in 2018, cancer, and permanent AF, presented with acute heart failure with predominant right-side failure. Severe tricuspid regurgitation was identified.
The operators implanted an Evoque valve percutaneously under TEE guidance and general anaesthesia via the venous...
Advanced mitral TEER - LIVE case
Recommended by PCR
24 Nov 2024 – From PCR London Valves 2024
Join us for a LIVE case followed by a recorded case highlighting advanced treatments for severe secondary mitral regurgitation:
- A 75-year-old man with permanent AF, a history of CABG, and symptomatic severe secondary MR (atrial and ischemic causes) with low LV function (45%) underwent mitral repair with...
Left main - LIVE Case
Recommended by PCR
10 Dec 2025 – From GulfPCR-GIM 2025
This session delivers an in-depth exploration of left main coronary artery intervention, featuring a live educational case from the Mohammed Bin Khalifa Bin Salman Al Khalifa Specialist Cardiac Centre in Awali, Bahrain. Attendees gain insights into the pivotal role of computed tomography and intravascular imaging in...
Case report: Renal denervation using ultrasound energy (uRDN)
23 Oct 2024
In this case report, we examine an advanced technique for renal denervation (RDN)—ultrasound energy—employed to manage severe hypertension in patients with complex medical histories.
Author
POPular PAUSE TAVI - Continuation or interruption of oral anticoagulation during TAVI?
02 Sep 2024
Luis Ortega-Paz provides his take on the POPular PAUSE TAVI trial presented by Dirk Jan van Ginkel at the ESC Congress 2024 in London.
Author
MATTERHORN - Transcatheter versus surgical mitral valve repair in patients with heart failure and secondary mitral regurgitation
01 Sep 2024
Yohei Ohno provides his takeaways from the results of the MATTERHORN trial presented by Volker Rudolph at the ESC Congress 2024 in London.
Author
ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation
31 Aug 2021
Following the Hot Line session of the ESC Congress 2021 presented by George Dangas (New-York, USA), Daniele Giacoppo offers us a condensed version of this study.
Author
OPTION – Indobufen or aspirin on top of clopidogrel after coronary drug-eluting stent implantation
08 Nov 2022
Ali Nazmi Calik provides his take on OPTION, which was presented during AHA 2022 in Chicago.
Author
Fractional flow reserve-guided complete or culprit-only PCI in patients with ST-elevation myocardial Infarction - FULL REVASC
08 Apr 2024
Nicola Ryan provides her take on the FULL REVASC trial which was presented at ACC.24 in Atlanta and published Simultaneously in NEJM.
The FULL REVASC trial is a multicentre registry-based randomised control trial comparing FFR-guided complete revascularisation of non-culprit lesions versus culprit lesion PCI alone in patients presenting...
Author
Future directions of drug-coated balloon angioplasty
06 Feb 2025
Fernando Alfonso and Javier Cuesta discuss the growing role of drug-coated balloons as an alternative to stents in percutaneous coronary interventions. Highlighting advantages like reduced in-stent restenosis, they emphasize the need for robust clinical studies to refine DCB use.
Author
Author
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
02 Sep 2025
Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...
Author
